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The IVth International Symposium on Neural
Transplantation was made possible through the
financial support provided by the National
Institute of Neurological Diseases and Stroke
(grant number NS-30608), National Institute of
Mental Health, National Institute on Aging, the
Axion Research Foundation, Paralyzed
Veterans of America, United Parkinson
Foundation, Spinal Victory Kent Waldrep
National Paralysis Foundation, American
Paralysis Association, Cytotherapeutics, Inc.,
Alzhheimer’s Disease and Related Disorders
Association, the American Parkinson Disease
Association, and the Cephalon Corporation. The
local and international organizing committees
extend their most sincere thanks to these
organizations for their support.
The meeting was attended by approximately
502 registrants, representing 27 nations. The
general consensus of those attending was that
the scientific quality of the material presented
was outstanding. Intriguing new work on the
application of tissue transplantation in animal
models of learning and memory disorders, pain,
depression, and Huntington’s disease, for
example, was presented. Other topics in which
new findings were presented included methods
of functional assessment, development of cell
lines and the use of alternate cell types for
transplantation, new transplantation methods
including encapsulation and the use of support
matrices, and the use of neuronal transplants to
examine the function and development of
neuronal circuits. Although clinical application
remains controversial, there continue to be
promising indications of positive clinical effects.
The large number of abstracts related to
Parldnson’s disease testifies both to the
continued interest and to promising recent
developments in this area. New technologies,
ranging from localized administration of growth
factors and drugs to the intracerebral
implantation of alternative tissues, genetically
altered cell lines, immunology, and artificial
growth-promoting substrates have helped to
expand the boundaries of research in neural
tissue transplantation.
Highlights from the meeting included:
The use of cell lines for transplantation,
including genetically modified cells and
immortalized cell lines. The two approaches for
generating transplantable cells differ markedly;
one approach seeks to introduce desirable
characteristics (e.g., eDNA encoding enzymes or
growth factors) into cells which already possess
the ability to reproduce in culture. The second
approach seeks to introduce the ability to
replicate indefinitely (i.e., immortalization), into
cells which already possess all of the other
desired functional properties. For example, in
the case of Parkinson’s disease models, the two
approaches are exemplified by studies which
seek to produce immortalized mesencephalic
neurons or adrenal chromaffin cells or,
conversely, to introduce tyrosine hydroxylase
eDNA into either primary cells (such as
astrocytes) or into cell lines, so that they produce
either dopamine or L-DOPA. Several papers
reported on the development of immortalized
cell lines, including mesencephalic cells or
Schwann cells, or on the development of
genetically modified astrocytes or fibroblasts
which produce NGF.
Methods for obtaining improved survival of
intracerebrally grafted chromaffin cells,
including co-transplantation with peripheral
nerve and pre-transected peripheral nerve,
infusions of nerve growth factor, the use of
preparations of purified chromaffin cells for
transplantation, and techniques for assisting
transport of nerve growth factor through the
blood-brain barrier were presented. This is
currently a major focus of research in adrenal
medulla transplantation in both animal models
and clinical studies.
Advances in clinical studies included longer
follow-up periods for earlier patient groups,
improved experimental design and assessment
methods, and progressive improvements in
transplantation techniques. Several studies
reported on long term clinical studies of fetal
tissue transplantation, with follow-up periods in
excess of two years. Some reports indicated
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progressive improvement continuing for more
than one year after transplantation. Donor tissue
age and transplantation site continue to be
major areas of controversy. Coordination of
studies through registries and standardized
assessment programs, and the possibility of
inclusion of control procedures or comparison
groups, also continued to be major topics of
discussion.
Parkinson’s disease continues to be a major
area of emphasis for studies of neural
transplantation, as evidenced by the substantial
number of papers on this topic. For example,
approximately 40 of the 95 extended abstracts in
this volume are directly related to Parkinson’s
disease. On the other hand, there was a
considerable number of exciting new
developments in other models ofCNS injury and
disorders, and in application of transplantation
for basic studies of development and neuronal
circuitry. The extended abstracts include papers
on models of pain, depression, epilepsy,
Huntington’s disease, cognitive dysfunction,
spinal cord injury, hypoxia/ischemia, activity-
based anorexia, and cortical injury. In the case of
pain models, the animal studies have led to
promising preliminary results in a clinical trial on
the application of adrenal medulla transplan-
tation in cancer patients with chronic pain.
The meeting proceedings will be communi-
cated through scientific journals according to the
following scheme: (i) Abstracts of essentially all
presented papers were published in a special
issue of Restorative Neurology and Neuro-
science (Volume 4 Number 3, July 1992). (ii)
The extended abstracts of selected papers,
submitted on the initiative of the presenters, are
published in the current issue. (iii) Five journals
(Experimental Neurology, Restorative Neuro-
logy and Neuroscience, Regional Immunology,
Cell Transplantation, and Journal of Neural
Transplantation and Plasticity) have agreed to
devote special issues to the publication of peer-
reviewed papers on the original data presented
at the meeting, at the participants’ initiative,
provided sufficient papers are received. (iv) The
Journal of Neural Transplantation and Plasti-
city (JNTP) will punish a report on the meeting
in 1993. When the list of meeting-related
citations is complete, it will be sent to anyone
sending a self-addressed envelope to the JNTP
editorial office.
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